Cited by

• Ginsenoside Rg1 improves bone marrow haematopoietic activity via extramedullary haematopoiesis of the spleen.

  Liu HH, Chen FP, Liu RK, Lin CL, Chang KT. Liu HH, et al. J Cell Mol Med. 2015 Nov;19(11):2575-86. doi: 10.1111/jcmm.12643. Epub 2015 Jul 8. J Cell Mol Med. 2015. PMID: 26153045 Free PMC article.
• Guide to drug dosage in renal failure.

  Bennett WM. Bennett WM. Clin Pharmacokinet. 1988 Nov;15(5):326-54. doi: 10.2165/00003088-198815050-00005. Clin Pharmacokinet. 1988. PMID: 3060292 Review. No abstract available.
• Antineoplastic drugs in 1990. A review (Part II).

  Black DJ, Livingston RB. Black DJ, et al. Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003. Drugs. 1990. PMID: 2191847 Review. No abstract available.
• Pharmacokinetics of intravenous and oral cyclophosphamide in the presence of methotrexate and fluorouracil.

  De Bruijn EA, Slee PH, Van Oosterom AT, Lameijer DW, Roozendaal KJ, Tjaden UR. De Bruijn EA, et al. Pharm Weekbl Sci. 1988 Oct 14;10(5):200-6. doi: 10.1007/BF01956871. Pharm Weekbl Sci. 1988. PMID: 3205676 Clinical Trial.
• Dose-dependent pharmacokinetics and cancer chemotherapy.

  Powis G, Ames MM, Kovach JS. Powis G, et al. Cancer Chemother Pharmacol. 1981;6(1):1-9. doi: 10.1007/BF00253003. Cancer Chemother Pharmacol. 1981. PMID: 7023712 Review.